SMA Type 1 diagnosis devastates Jesy Nelson’s family, but her brave revelation could change lives forever

SMA Type 1 is a devastating genetic disorder that affects how muscles function throughout the body. Former Little Mix star Jesy Nelson revealed today that her twin daughters have been diagnosed with this rare condition, sparking important conversations about early detection and treatment options.

Understanding SMA Type 1: What Every Parent Should Know

Spinal Muscular Atrophy is a rare genetic condition that causes progressive muscle weakness. SMA Type 1, also called Werdnig-Hoffman disease, is the most severe form and accounts for approximately 60% of all SMA cases. The condition affects roughly 1 in 6,000 to 10,000 live births, making it one of the most common severe inherited disorders of infancy and childhood after cystic fibrosis.

In SMA Type 1, the body loses the ability to produce a critical protein called SMN (Survival Motor Neuron). This protein deficiency causes motor neurons in the spinal cord to break down, leading to muscle deterioration. Without treatment, infants typically decline rapidly, affecting their ability to breathe, swallow, and move.

Jesy Nelson’s Heartbreaking Announcement and Her Twin Daughters

Jesy Nelson, the 34-year-old singer, shared the diagnosis in an emotional Instagram video posted earlier today. She revealed that her daughters Ocean Jade and Story Monroe Nelson-Foster showed signs of muscle weakness early, with insufficient leg movement and feeding difficulties during their first months of life.

After three to four months of gruelling medical appointments and assessments at Great Ormond Street Hospital in London, doctors confirmed the diagnosis. Jesy explained that without treatment, her daughters’ life expectancy would not extend past age two. She described the past three months as “the most heartbreaking time of my life” but expressed determination that her girls will “defy all the odds.”

Life-Saving Treatment and Early Intervention

Aspect	Details
Diagnosis Type	Spinal Muscular Atrophy Type 1
Severity Level	Most severe form affecting all muscles
Primary Treatment	Gene Therapy (Zolgensma) – delivers healthy genes
Current Status	Receiving treatment with positive outlook
Age of Diagnosis	8 months old

The twins have already started receiving treatment, a breakthrough that Jesy credits with potentially saving their lives. The most significant advancement in SMA care came in 2021 when the NHS approved Zolgensma, a gene therapy drug that delivers a healthy copy of the affected gene directly to the body. This treatment has transformed outcomes for infants diagnosed early. However, timing is critical—once irreversible nervous system damage occurs, even the best treatments have limitations.

From Personal Struggle to Advocacy: Jesy’s Mission

Beyond sharing her personal journey, Jesy Nelson stated she wanted to make her announcement public to help other children get diagnosed as quickly as possible. She noted the importance of early detection and how parents can notice warning signs like reduced leg movement versus expected developmental milestones.

Currently, SMA screening is only offered to babies with a family history of the condition. However, advocacy organizations like SMA UK are pushing for expanded screening. The charity wants SMA included in the standard newborn blood spot test that already screens for 10 other rare but serious conditions. This expansion could detect many more cases before irreversible damage occurs, potentially changing lives like Ocean Jade and Story Monroe’s.

What Does This Mean for SMA Type 1 Awareness and Future Families?

Jesy Nelson’s announcement brings significant attention to a condition many families have never heard of before diagnosis strikes. The two-year life expectancy without treatment and devastating impact make SMA Type 1 a medical emergency once suspected. Yet awareness remains low because it’s rare, meaning early diagnosis often depends on family history or alert healthcare providers noticing developmental delays.

The estimated 47 babies born with SMA in the UK during 2024 represent only the diagnosed cases. Approximately 1 in 40 people carry the altered gene that can pass the condition to children, though carriers typically show no symptoms. This means many families face this diagnosis without warning, just as Jesy did despite her daughters’ premature birth alerting medical teams to monitor carefully. Her willingness to share this journey publicly transforms personal tragedy into a platform for change, potentially accelerating universal newborn screening initiatives.

“After the most gruelling three, four months, and endless appointments, the girls have now been diagnosed with a severe muscular disease called SMA type 1. The reason I wanted to make this video was because the last three months have honestly been the most heartbreaking time of my life.”

— Jesy Nelson, Former Little Mix Star and Mother

Sources

• BBC News – Jesy Nelson’s official announcement and SMA medical background
• Great Ormond Street Hospital – Diagnosis and treatment information
• SMA UK – Screening and awareness advocacy details